| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 08/06/2013 | US8502016 Genomic alpha synuclein transgenic animal |
| 08/06/2013 | US8502004 Process for evaluating a refinery feedstock |
| 08/06/2013 | US8501921 Detection of target analytes using particles and electrodes |
| 08/06/2013 | US8501668 Drug screening via nanopore silicon filters |
| 08/06/2013 | US8501498 Mass tags for quantitative analyses |
| 08/06/2013 | US8501497 Forming sample combinations using liquid bridge systems |
| 08/06/2013 | US8501496 Immunoassay cuvettes |
| 08/06/2013 | US8501495 Sequential solid phase immunoassay including contact pad to limit conjugate flow during manufacture |
| 08/06/2013 | US8501494 Method and device for detecting prior drug use, taking inflammation into account to increase test's specificity and reduce false positives |
| 08/06/2013 | US8501491 Method of measuring concentration of fuel |
| 08/06/2013 | US8501490 Bioassays based on polymeric sequence probe |
| 08/06/2013 | US8501489 Urinary biomarkers to predict long-term dialysis |
| 08/06/2013 | US8501488 Proteolysis via trypsin; mass spectrometry |
| 08/06/2013 | US8501486 Materials and methods for isolating phosphopeptides |
| 08/06/2013 | US8501485 Risk stratification for acute coronary syndrome by determining copeptin |
| 08/06/2013 | US8501484 Preparation of cerium halide solvate complexes |
| 08/06/2013 | US8501483 Method of assessing cancer status in a breast cancer patient |
| 08/06/2013 | US8501482 Apparatus for analyzing particles in urine and method thereof |
| 08/06/2013 | US8501480 High throughput screening of fatty acid composition |
| 08/06/2013 | US8501427 Factor H polymorphisms in the diagnosis and therapy of inflammatory diseases such as age-related macular degeneration |
| 08/06/2013 | US8501426 Method for identifying protease inhibitors |
| 08/06/2013 | US8501425 Detection of chronic and acute pulmonary inflammation |
| 08/06/2013 | US8501424 Cd4+ epitopes of bone morphogenetic proteins |
| 08/06/2013 | US8501423 Measuring circulating therapeutic antibody, antigen and antigen/antibody complexes using ELISA assays |
| 08/06/2013 | US8501422 Methods of detecting and treating pulmonary disease and markers thereof |
| 08/06/2013 | US8501421 Method for high throughput peptide/protein assay generation and assays generated therewith |
| 08/06/2013 | US8501419 Exposed proliferation-related peptides, ligands and methods employing the same |
| 08/06/2013 | US8501418 Method of treating renal dysfunction based on perlecan as a biomarker |
| 08/06/2013 | US8501417 Immunological compositions as cancer biomarkers and/or therapeutics |
| 08/06/2013 | US8501416 Fluidic structures including meandering and wide channels |
| 08/06/2013 | US8501415 Identification of TSH receptor autoantibodies using affinity-purified antibodies |
| 08/06/2013 | US8501402 Preparing pharmaceutical grade plasmids for use as gene transfer tools in genetic engineering |
| 08/06/2013 | US8501399 Asymmetrically branched polymer conjugates and microarray assays |
| 08/06/2013 | US8501398 Luminescence assay using macrocyclic lanthanide (III) complexes |
| 08/06/2013 | US8501113 Fluorescence spectroscopy in absorbing media |
| 08/06/2013 | US8501112 Body fluid analysis fixture |
| 08/06/2013 | US8501101 Gas sensor |
| 08/06/2013 | US8501097 Reliable switch that is triggered by the detection of a specific gas or substance |
| 08/06/2013 | US8501095 Method of dispensing biosensors |
| 08/06/2013 | US8501092 Calorimeter and methods of use thereof |
| 08/06/2013 | US8501000 Methods and device employing centrifugal force |
| 08/06/2013 | US8500637 Viscosimetric biosensor for monitoring analyte levels |
| 08/06/2013 | CA2714309C System and method for analyte measurement using dose sufficiency electrodes |
| 08/06/2013 | CA2703447C Multi-chambered tissue containment system for molecular and histology diagnostics |
| 08/06/2013 | CA2635238C Improvements in and relating to imaging of biological samples |
| 08/06/2013 | CA2619079C Method of stabilizing pulmonary surfactant protein |
| 08/06/2013 | CA2600000C Method for determining absolute density of cement slurry |
| 08/06/2013 | CA2598253C Human ring specific bnp antibodies |
| 08/06/2013 | CA2583908C Fiber optic device for sensing analytes and method of making same |
| 08/06/2013 | CA2582462C Prion protein binding materials and methods of use |
| 08/06/2013 | CA2577463C Process for identification of compounds for modulating the activity of a sodium/calcium exchange transporter |
| 08/06/2013 | CA2569472C Electrochemical urea sensors and methods of making the same |
| 08/06/2013 | CA2536360C Methods and apparatus for sorting cells using an optical switch in a microfluidic channel network |
| 08/06/2013 | CA2521826C Recombinant il-9 antibodies and uses thereof |
| 08/06/2013 | CA2489214C Anti-aurora-a monoclonal antibody, method for obtaining same, and uses thereof for diagnosing and treating cancers |
| 08/06/2013 | CA2425779C Compositions that inhibit proliferation of cancer cells |
| 08/06/2013 | CA2329684C Cyclin-dependent kinase inhibitors as plant growth regulators |
| 08/06/2013 | CA2189585C Control solution and method for testing the performance of an electrochemical device for determining the concentration of an analyte in blood |
| 08/01/2013 | WO2013113018A1 Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
| 08/01/2013 | WO2013113001A1 Robotic end effector for frozen aliquotter and methods of taking a frozen aliquot from biological samples |
| 08/01/2013 | WO2013112999A1 Methods and arrays for controlled manipulation of dna and chromatin fragments for genetic and epigenetic analysis |
| 08/01/2013 | WO2013112956A1 Systems and methods for protein melt analysis using dipyrrometheneboron difluoride compounds |
| 08/01/2013 | WO2013112942A1 Biomarkers and combination therapies using oncolytic virus and immunomodulation |
| 08/01/2013 | WO2013112933A1 Identification of new therapeutic uses for known therapeutic agents |
| 08/01/2013 | WO2013112891A1 Methods and compositions for hematoxylin and eosin staining |
| 08/01/2013 | WO2013112881A1 Mct protein inhibitor-related prognostic and therapeutic methods |
| 08/01/2013 | WO2013112865A1 Diagnosis and treatment for respiratory tract diseases |
| 08/01/2013 | WO2013112836A2 Diagnostic and prognostic biomarkers for cancer |
| 08/01/2013 | WO2013112745A1 Peptide identification and sequencing by single-molecule detection of peptides undergoing degradation |
| 08/01/2013 | WO2013112742A1 High range activated clotting time assay formulation |
| 08/01/2013 | WO2013112698A1 Methods and systems for long distance tagging, tracking, and locating using wavelength upconversion |
| 08/01/2013 | WO2013112655A1 Method for correction of bias in multiplexed amplification |
| 08/01/2013 | WO2013112602A1 Soluble manf in pancreatic beta-cell disorders |
| 08/01/2013 | WO2013112601A1 Methods of treatment of cancer |
| 08/01/2013 | WO2013112548A1 Gamma-aapeptides with potent and broad-spectrum antimicrobial activity |
| 08/01/2013 | WO2013112528A1 Methods and compositions relating to proliferative disorders of the prostate |
| 08/01/2013 | WO2013112274A1 Systems, methods and devices for analyzing drilling fluid |
| 08/01/2013 | WO2013112216A1 System for detecting infection in synovial fluid |
| 08/01/2013 | WO2013112164A1 Graphene membrane with regular angstrom-scale pores |
| 08/01/2013 | WO2013112162A1 Fast flow apparatus and method to evaluate analytes in liquid, solid and semi-solid samples |
| 08/01/2013 | WO2013112103A1 Method of detecting tuberculosis |
| 08/01/2013 | WO2013111953A2 Method for detecting and quantifying target proteins or target cells using aptamer chips |
| 08/01/2013 | WO2013111926A1 Cartridge provided with standard alcohol gas for breathalyzer |
| 08/01/2013 | WO2013111925A1 Breathalyzer |
| 08/01/2013 | WO2013111909A1 METHOD FOR SCREENING FOR Nrf1 REGULATOR |
| 08/01/2013 | WO2013111897A1 Novel antitumor agent and method for screening same |
| 08/01/2013 | WO2013111820A1 Method for quantifying cholesterol in high density lipoprotein 3 |
| 08/01/2013 | WO2013111770A1 Novel anti-malignant tumor agent |
| 08/01/2013 | WO2013111719A1 Photodynamic diagnostic agent and photobleaching inhibitor |
| 08/01/2013 | WO2013111668A1 Fish assay for detecting translocation between kif5b gene and ret gene |
| 08/01/2013 | WO2013111578A1 Diagnosis method and diagnosis system for alzheimer's disease |
| 08/01/2013 | WO2013111528A1 Diagnostic agent for tumor |
| 08/01/2013 | WO2013111448A1 Human papilloma virus type 16l1-derived b cell epitope peptide |
| 08/01/2013 | WO2013111054A1 Methods for detecting 5t4-positive circulating tumor cells and methods of diagnosis of 5t4-positive cancer in a mammalian subject |
| 08/01/2013 | WO2013111045A1 Use of waste products for detecting amyloidogenic proteinaceous material in living mammals |
| 08/01/2013 | WO2013110894A1 Method for the in vitro prediction of the probability of a patient developing severe dengue, based on a blood sample |
| 08/01/2013 | WO2013110837A1 Haptens, conjugates and antibodies for pyrimethanil fungicide |
| 08/01/2013 | WO2013110825A1 Integrated data recognition system for locking and/or unlocking motor-actuated objects, mechanisms, devices and/or similar in any medium |
| 08/01/2013 | WO2013110808A2 Methods and kits for determining whether a patient with cirrhosis is at risk of having clinically significant portal hypertension |
| 08/01/2013 | WO2013110734A1 Device for early detection of micro-organisms |